• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Hem Onc Area Business Mgr

Anonymous

Guest
What is the status of this salesforce? Are they currently selling in hem onc (Rituxan? thought only Genentech was promoting in hem onc?) or new sales force for coming hemophilia products?